Immune modulation
Showing 1 - 25 of >10,000
Triple Negative Breast Cancer Trial (Cryoablation, Cryoablation combined with PD1 Inhibitor)
Not yet recruiting
- Triple Negative Breast Cancer
- Cryoablation
- Cryoablation combined with PD1 Inhibitor
- (no location specified)
Mar 28, 2023
COVID-19 Trial in Minneapolis (abatacept infusion, Placebo group)
Not yet recruiting
- COVID-19
- abatacept infusion
- Placebo group
-
Minneapolis, MinnesotaUniversity of Minnesota
Apr 18, 2023
Actinic Keratosis, Photodynamic Therapy Trial in Fairborn (Celecoxib 200mg, Placebo)
Recruiting
- Actinic Keratosis
- Photodynamic Therapy
- Celecoxib 200mg
- Placebo
-
Fairborn, OhioWright State Physicians
Jan 9, 2023
Reduction of Peanut Reactivity and Immune Modulation With
Recruiting
- Peanut Allergy
-
New York, New YorkDepartment of Genetic Medicine, Weill Cornell Medicine
Feb 23, 2022
COVID-19, Critical Illness, Hypercytokinemia Trial in Ulm (Application of exosomes in a whole blood assay)
Recruiting
- COVID-19
- +3 more
- Application of exosomes in a whole blood assay
-
Ulm, GermanyUlm University Hospital, Clinic of Anesthesiology and Intensive
Jan 17, 2022
Colon Cancer Trial in Boston (AMR101 (VASCEPA, icosapent ethyl))
Withdrawn
- Colon Cancer
- AMR101 (VASCEPA, icosapent ethyl)
-
Boston, MassachusettsMassachusetts General Hospital
Nov 10, 2021
Chronic Rhinosinusitis With Nasal Polyps Trial in Vancouver (Mepolizumab)
Not yet recruiting
- Chronic Rhinosinusitis With Nasal Polyps
-
Vancouver, British Columbia, CanadaSt. Paul's Sinus Centre
Oct 24, 2023
Oligometastatic Prostate Cancer Trial in New York (Quemliclustat, Etrumadenant, Zimberelimab)
Not yet recruiting
- Oligometastatic Prostate Cancer
- Quemliclustat
- +3 more
-
New York, New YorkColumbia University Irving Medical Center / NewYork-Presbyterian
Jun 14, 2023
Surgery, Immune System and Related Disorders, Preoperative Care Trial in Stanford (Physical Prehabilitation, Stress Reduction
Recruiting
- Surgery
- +6 more
- Physical Prehabilitation
- +3 more
-
Stanford, CaliforniaStanford University
Nov 26, 2021
Atopic Dermatitis Trial in Berlin (not applicable, observational study)
Recruiting
- Atopic Dermatitis
- not applicable, observational study
-
Berlin, GermanyDpt of Dermatology and Allergology, Charité - Universitätsmedizi
Oct 20, 2021
Human Immunodeficiency Virus (HIV) Infection, Hypercholesterolemia Trial in Columbus (Soy Pretzel, Wheat Pretzel)
Recruiting
- Human Immunodeficiency Virus (HIV) Infection
- Hypercholesterolemia
- Soy Pretzel
- Wheat Pretzel
-
Columbus, OhioThe Ohio State University Medical Center
Sep 19, 2022
Osteoarthritis, Knee, Osteo Arthritis Knee, Knee Osteoarthritis Trial (GNSC-001, transient immune-modulation, Placebo)
Not yet recruiting
- Osteoarthritis, Knee
- +9 more
- GNSC-001
- +2 more
- (no location specified)
Apr 19, 2023
Metastatic Melanoma Trial in Pierre-Bénite (Blood and biopsy sampling)
Completed
- Metastatic Melanoma
- Blood and biopsy sampling
-
Pierre-Bénite, FranceService de Dermatologie, Centre Hospitalier Lyon Sud (HCL)
Dec 23, 2021
Hepatocellular Cancer, Gastrointestinal Cancer, Immunosuppression Trial in Taipei (Modern acupuncture)
Completed
- Hepatocellular Cancer
- +2 more
- Modern acupuncture
-
Taipei, TaiwanWanFangH
Dec 29, 2020
High-risk cSCC Treated With Surgery and Radiotherapy
Not yet recruiting
- Squamous Cell Carcinoma of the Skin
- Peripheral blood sampling in order to evaluate changes in the circulating immune population
- (no location specified)
Feb 15, 2022
Allergic Rhinitis Trial in Taoyuan (Shin-yi-san + Xiao-qing-long-tang + Xiang-sha-liu-jun-zi-tang by the weight of 9g+3g+3g/day)
Completed
- Allergic Rhinitis
- Shin-yi-san + Xiao-qing-long-tang + Xiang-sha-liu-jun-zi-tang by the weight of 9g+3g+3g/day
-
Taoyuan, TaiwanChang Gung Memorial Hospital
Feb 5, 2021
Colorectal Cancer Stage IV Trial in Sherbrooke (Resting state (Control), Moderate Intensity Continuous Exercise (MICE), High
Recruiting
- Colorectal Cancer Stage IV
- Resting state (Control)
- +2 more
-
Sherbrooke, Quebec, CanadaResearch Centre on Aging
May 16, 2022
Metastatic Melanoma Naive to Immune Therapy in Metastatic Setting Trial in Lausanne (Pembrolizumab, Pembrolizumab - additional
Active, not recruiting
- Metastatic Melanoma Naive to Immune Therapy in Metastatic Setting
- Pembrolizumab
- Pembrolizumab - additional treatment
-
Lausanne, SwitzerlandOlivier Michielin
Jan 17, 2022
COVID-19, Vaccine Reaction, Elderly Trial (Taking capsule containing probiotics or )
Not yet recruiting
- COVID-19
- +2 more
- Taking capsule containing probiotics or placebo
- (no location specified)
May 16, 2022